Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis
Authors:
- Joanna Wedgwood-KruckoJWJoanna Wedgwood-Krucko
- Susanne SuterSSSusanne Suter
- Richard KraemerRKRichard Kraemer
- 1 October 1987
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 111 (4) , 599-605
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antibiotic therapy in cystic fibrosis: Evaluation of clinical trialsThe Journal of Pediatrics, 1986
- Inhaled antibiotics in cystic fibrosis: Is there a therapeutic effect?The Journal of Pediatrics, 1986
- Management of acute pulmonary exacerbations in cystic fibrosis: A critical appraisalThe Journal of Pediatrics, 1985
- Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosisThe Pediatric Infectious Disease Journal, 1985
- Antibiotic Use in Cystic FibrosisDrug Intelligence & Clinical Pharmacy, 1984
- Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosisThe Pediatric Infectious Disease Journal, 1983
- The art and science of the use of antibiotics in cystic fibrosisThe Pediatric Infectious Disease Journal, 1982
- ANTIMICROBIAL CHEMOTHERAPY IN CYSTIC FIBROSIS PATIENTSActa Paediatrica, 1982
- The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosisThe Journal of Pediatrics, 1981
- Assay of ceftazidime in biological fluids using high-pressure liquid chromatographyJournal of Antimicrobial Chemotherapy, 1981